caa a22 4500 475771826 CHVBK 20180406123619.0 cr unu---uuuuu 170329e20000301xx s 000 0 eng 10.1007/s001250050055 doi (NATIONALLICENCE)springer-10.1007/s001250050055 Analysis of the HNF4 α gene in Caucasian Type II diabetic nephropathic patients [Elektronische Daten] [J. A. Price, S. C. Fossey, M. M. Sale, C. S. Brewer, B. I. Freedman, J.-P. Wuerth, D. W. Bowden] Aims/hypothesis. Linkage and association studies in Caucasian patients with Type II (non-insulin-dependent) diabetes mellitus suggest that one or more diabetes susceptibility gene(s) reside within human chromosome 20q12-13.1. This region of chromosome 20 contains the maturity-onset diabetes of the young type 1 gene, HNF4 α. The purpose of this study was to assess the possible involvement of HNF4 α in Type II diabetes.¶Methods. Mutation analysis was done on the 12 exons and promoter regions of the HNF4 α gene in 182 Caucasian diabetic nephropathic patients and 100 Caucasian control subjects. The functional consequences of a novel promoter mutation were examined using a reporter system in the HepG2 liver cell line and electrophoretic mobility shift assays.¶Results. We identified two novel mutations in the HNF4α, an R323H missense mutation in exon 8, and a 7 bp deletion (Δ7) in the proximal promoter region resulting in deletion of a single putative Sp1 binding site. Using a reporter assay system, the Δ7 sequence was found to exhibit a 51.2 % (standard error ± 4.2 %) reduction in promoter activity relative to the normal sequence. In electrophoretic mobility shift assays using specific and non-specific competitors, the Δ7 sequence had a 45.5 % (range 40.4-46.6) reduction in binding compared with the normal sequence. The Δ7 allele occurs in a family with multiple cases of Type II diabetes in a pattern consistent with coinheritance of the Δ7 allele and diabetes.¶Conclusion/interpretation. Analysis of the HNF4 α gene revealed two possible mutations in 182 diabetic patients which suggests that the HNF4 α gene does not make a large contribution to diabetes susceptibility in the general population of Caucasian diabetic nephropathic patients. Functional analysis of the Δ7 promoter deletion suggests, however, that promoter mutations in otherwise normal genes could contribute to diabetes susceptibility. [Diabetologia (2000) 43: 364-372] Springer-Verlag Berlin Heidelberg, 2000 Keywords Hepatocyte nuclear factor, Type II diabetes, transcription factors, gene expression, promoter nationallicence Price J. A. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA, US aut Fossey S. C. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA, US aut Sale M. M. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA, US aut Brewer C. S. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA, US aut Freedman B. I. Department of Internal Medicine, Section of Nephrology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA, US aut Wuerth J.-P Alteon Inc., Ramsey, New Jersey, USA, US aut Bowden D. W. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA, US aut https://doi.org/10.1007/s001250050055 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s001250050055 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Price J. A. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA, US aut NATIONALLICENCE 700 1- Fossey S. C. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA, US aut NATIONALLICENCE 700 1- Sale M. M. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA, US aut NATIONALLICENCE 700 1- Brewer C. S. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA, US aut NATIONALLICENCE 700 1- Freedman B. I. Department of Internal Medicine, Section of Nephrology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA, US aut NATIONALLICENCE 700 1- Wuerth J.-P Alteon Inc., Ramsey, New Jersey, USA, US aut NATIONALLICENCE 700 1- Bowden D. W. Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA, US aut Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer